Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philippines Reports Drug Makers Volunteered Price Cuts On 23 Drugs

This article was originally published in PharmAsia News

Executive Summary

The Philippines authorities report that although drug makers fell short of the 21 "essential" medicines whose prices they were asked to cut by 50 percent, they did propose reductions in the prices of 23 other drugs. The National Drug Policy unit of the Health Department is reviewing the 23 additional drugs listed by pharmaceutical companies as those with prices they would cut by 10 percent to 50 percent. The proposals still have to be approved along with a government response to ordered cuts in the prices of the six essential drugs the companies did not volunteer to cut. (Click here for more

You may also be interested in...



Biden Health Plan: Think ‘Health Security,’ Not ‘Medicare For All’

The Democratic Primary focused heavily on the idea of ‘Medicare for All,’ but the emergence of former Vice President Biden as the party standard bearer – and the overwhelming impact of the COVID-19 outbreak – suggests a very different theme for the national campaign.

QUOTED. 3 June 2020. Stephen Hahn.

In a 1 June speech before the Alliance For a Stronger FDA, US FDA commissioner Stephen Hahn stressed the agency’s vigilance in guarding against consumer use of flawed COVID-19 products. He also made comments about the need for doctors to communicate more with patients. See what he said about the use of telehealth here.

House Committees Want BARDA Coronavirus Vaccine, Treatment Contract Info

Request for documents and a briefing is part of efforts to ensure federal programs are ‘protected from price gouging.’

UsernamePublicRestriction

Register

RS009715

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel